THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR (CV) EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) IN TURKEY


Creative Commons License

Parali E., Deger C., Ozdemir O., AFSAR N., Aykut Aka S., Degertekin M., ...Daha Fazla

VALUE IN HEALTH, cilt.17, sa.3, 2014 (SCI-Expanded, SSCI, Scopus)